ライフサイエンスコーパス: clonazepam

1 d sertraline plus placebo or sertraline plus clonazepam.

2 hibition with picrotoxin or enhanced it with clonazepam.

3 r sertraline plus placebo or sertraline plus clonazepam.

4 One-half of these patients received clonazepam, 0.5 mg h.s. adjusted to two tablets by day 1

5 to groups receiving either 0.5 mg of active clonazepam 3 times daily or placebo clonazepam for the f

6 to 3.0 mg/day of clonazepam (sertraline plus clonazepam), a switch to up to 225 mg/day of venlafaxine

7 red network firing pattern was normalized by clonazepam, a positive modulator of the GABAA receptor.

8 27% of patients assigned to sertraline plus clonazepam achieved remission compared with patients ass

9 nt GABA neuronal response to benzodiazepine (clonazepam) administration.

10 Midazolam, but not clonazepam, also augmented a form of spike inhibition af

11 compared midazolam, an anesthetic BDZ, with clonazepam, an anticonvulsant/anxiolytic BDZ that activa

12 A solution of 4 mg of clonazepam and 2 mg of flunitrazepam, each dissolved in

13 A(A) receptor positive allosteric modulators clonazepam and allopregnanolone, and by the NMDA recepto

14 The findings suggest that clonazepam and flunitrazepam influence C. vicina morphol

15 he current study investigated the effects of clonazepam and flunitrazepam on the development cycle of

16 While clonazepam and melatonin are most commonly used as sympt

17 d group received a single oral dose of 0.5mg clonazepam, and the remaining patients received placebo.

18 e and adjunctive medications (eg, clonidine, clonazepam, antiemetics) for opioid withdrawal.

19 ls ranged from 3.01 (95% CI = 1.53-5.94) for clonazepam + atorvastatin with cefuroxime to 1.42 (95% C

20 Clonazepam augmentation correlated positively with the r

21 ach efficacy, the authors determined whether clonazepam augmentation of fluoxetine is superior to flu

22 Clonazepam augmentation of fluoxetine was superior to fl

23 The findings suggest that the clonazepam augmentation strategy provides relative benef

24 of mitochondrial Na(+)/Ca(2+) exchange with clonazepam blocked mitochondrial Ca(2+) efflux and resul

25 We confirm the effectiveness of clonazepam, but note that attention to the safety of the

26 2 microM) and the Na+/Ca2+ exchange blocker, clonazepam, (CLO, 20 microM) reversibly inhibited both t

27 oms can be safely achieved with a sertraline/clonazepam combination, supporting the clinical utility

28 r proportion of responders in the sertraline/clonazepam compared with the sertraline/placebo group at

29 he thalamic effects of the anti-absence drug clonazepam (CZP) are restricted to either relay or retic

30 CAP A3 and, partially, A2 subtypes), whereas clonazepam did the opposite, reducing non-rapid eye move

31 The clonazepam dose was then tapered during 3 weeks and disc

32 f variance confirmed a significant effect of clonazepam for average Hamilton depression scores.

33 f active clonazepam 3 times daily or placebo clonazepam for the first 4 weeks of the trial.

34 in the sertraline/placebo vs the sertraline/clonazepam group (38% vs 25%) (P =.5).

35 roportion of patients in the sertraline plus clonazepam group (56%) compared with the sertraline plus

36 week 3 with 14 (63%) of 22 of the sertraline/clonazepam group responding to treatment vs 8 (32%) of 2

37 Clonazepam had similar effects as CGP37157.

38 The patients taking clonazepam improved significantly more during the first

39 Midazolam, but not clonazepam, increased neurosteroid levels in CA1 pyramid

40 al period (occasionally prenatally) and that clonazepam is the treatment of choice (95% found it to b

41 7157 (CGP)], a benzothiazepine derivative of clonazepam, is commonly used as a blocker of the mitocho

42 o distinct cell populations that differed in clonazepam modulation and patterns of alpha-subunit expr

43 Prenatal exposure to clonazepam monotherapy was also associated with increase

44 mmonly cited RBD treatments include low-dose clonazepam or high-dose melatonin taken orally at bedtim

45 epin, oxcarbazepine, gapapentin, pregabalin, clonazepam, or phenobarbital.

46 f GABAergic transmission with tiagabine plus clonazepam partially rescues the effects of deletion of

47 Clonazepam/placebo was gradually discontinued during day

48 died, such as ketamine, midazolam, diazepam, clonazepam, propofol, pentobarbital, chloral hydrate, ha

49 levodopa, rotigotine, clozapine, duloxetine, clonazepam, ramelteon, gabapentin, zonisamide, and yokuk

50 e alone: the addition of up to 3.0 mg/day of clonazepam (sertraline plus clonazepam), a switch to up

51 Clonazepam studies illustrate how this approach disentan

52 10 were randomly assigned to sertraline plus clonazepam, switch to venlafaxine, or sertraline plus pl

53 trexate, zaleplon, metronidazole, lorazepam, clonazepam, temazepam, and zolpidem, among others, are p

54 or older who had used lorazepam, alprazolam, clonazepam, temazepam, and/or zolpidem for current or pr

55 Clonazepam treatment of RBD was completely or partially

56 tetrabenazine (one); and the introduction of clonazepam (two).

57 nerally similar, except for a notably higher clonazepam use in dementia convertors (OR = 2.6).

58 Sertraline plus clonazepam was associated with a significantly greater d

59 selective TSPO agonist, or a combination of clonazepam with exogenous allopregnanolone.

60 ic effects were mimicked by a combination of clonazepam with FGIN (2-[2-(4-fluorophenyl)-1H-indol-3-y

61 st the efficacy of early coadministration of clonazepam with sertraline in the treatment of panic dis